Par Pharmaceuticals Articles
TPG completes $1.9 billion acquisition of Par Pharma
1 October 2012
Par Pharma acquires Handa's ANDA for generic Dexilant
23 April 2012
Par Pharma challenges FDA authority on off-label promotion
23 October 2011
Intellipharmaceutics and Par Pharma expand Focalin accord
19 August 2011
Lupin settles Lunesta patent litigation with Dainippon Sumitomo; Par Pharma starts shipping generic Rythmol and Lotrel
5 January 2011
Showing 1-11 of 11 articles
- 1
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
